BUY IPCA Laboratories Limited — Emkay Global
byEmkay GlobalHorizon: NA (inferred 1 year)17 Aug 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Lyka Labs standalone profit surges 159% in Q1FY27 on export strength
NewsGoogle News·23 Aug · yesterday
Ipca Laboratories: Motilal Oswal Sets Rs 2,060 Target After Q1 Beat
NewsGoogle News·18 Aug · 1w ago
Ipca Laboratories: Motilal Oswal வழங்கும் ₹2,060 டார்கெட் விலை!
NewsGoogle News·18 Aug · 1w ago
Ipca Laboratories Share Price: ਕੰਪਨੀ ਨੇ ਕਮਾਇਆ ਰਿਕਾਰਡ ਮੁਨਾਫਾ, ਸ਼ੇਅਰਾਂ 'ਚ ਆਈ 12% ਤੇਜ਼ੀ
NewsGoogle News·17 Aug · 1w ago
Ipca Laboratories Share: तूफानी तेजी! Q1 नतीजों के बाद स्टॉक रिकॉर्ड हाई पर, 12% उछला
NewsGoogle News·17 Aug · 1w ago
Ipca Laboratories shareholders approve all resolutions at 76th AGM
NewsGoogle News·14 Aug · 1w ago
IPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·13 Aug · 2w ago
Standalone and Consolidated Unaudited Financial Results for Q1FY27
BSE · Board Meeting·13 Aug · 2w ago
Lyka Labs Limited Passes All Five Resolutions at 47th Annual General Meeting
NewsGoogle News·11 Aug · 2w ago
Ipca Labs Falls 2% As Profit-Booking Follows Q1 Results
NewsGoogle News·14 Aug · 2w ago
Ipca Laboratories Share: ફાર્મા કંપનીના શેરમાં **2%**નો ઘટાડો, જાણો કારણ અને આગામી ડેટ્સ
NewsGoogle News·6 Aug · 3w ago
Ipca Laboratories Shares: ਮਾਰਕੀਟ 'ਚ ਗਿਰਾਵਟ, ਸ਼ੇਅਰ **2%** ਡਿੱਗਿਆ
NewsGoogle News·6 Aug · 3w ago
Ipca Laboratories Share Price: मिडकैप इंडेक्स में गिरावट का असर, स्टॉक **2%** फिसला
NewsGoogle News·6 Aug · 3w ago
Krebs Biochemicals & Industries: Ipca Labs உடன் இணைப்புக்கு ஒப்புதல்! நஷ்டம் குறைவு, ஆனால் சிக்கல் தொடர்கிறது
NewsGoogle News·6 Aug · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
- BUY — Vikas Sethi, Sethi Finmart1 Oct 2026 · ~2 weeks · target ₹1,990 · SL hit
- BUY — Siddharth Rai Mangala25 Sept 2026 · ~2 weeks · target ₹2,060 · SL hit
More from Emkay Global
- BUY Eternal22 Oct 2026 · ~1 year · target ₹420 · Active
- BUY Piramal Finance21 Oct 2026 · ~1 year · target ₹2,100 · Active
- BUY Urban Company19 Oct 2026 · ~1 year · target ₹200 · Active
- BUY ICICI Bank19 Oct 2026 · ~1 year · target ₹1,785 · Active
- BUY Ujjivan Small Finance Bank19 Oct 2026 · ~1 year · target ₹90 · Active

